BOLTON SECURITIES CORPORATION’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
BOLTON SECURITIES CORPORATION's ROIV Position: Q1 2026 in Review
BOLTON SECURITIES CORPORATION opened a new position in Roivant Sciences (ROIV) in Q1 2026: 405 shares worth $11.2K. The stake represents ﹤0.01% of the portfolio and ranks #1589 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in ROIV as recently as Q3 2025.
BOLTON SECURITIES CORPORATION first reported a position in ROIV in Q3 2025 and has held it in 2 quarters since. 449 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.
- BOLTON SECURITIES CORPORATION held 405 shares of Roivant Sciences worth $11.2K as of Q1 2026.
- Roivant Sciences was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
- Roivant Sciences made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1589 holding.
- BOLTON SECURITIES CORPORATION first reported a position in Roivant Sciences in Q3 2025 and has held it in 2 quarters since.
- 449 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.
Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.